|Asoxime Chloride||Asparagus||Aspergillic Acid||Aspergillin||Asperlicin|
|Systematic (IUPAC) name|
|Mol. mass||449.582 g/mol|
|(what is this?)|
Asoprisnil (J867) is an investigational selective progesterone receptor modulator developed by Schering and TAP Pharmaceutical Products, tested for treatment of progesterone sensitive myomata.
In 2005, Phase III trials were discontinued due to endometrial changes in patients. It is uncertain whether asoprisnil will be marketed.